Design Therapeutics Inc (DSGN)

SG&A Expense Growth

8.67%

Quarterly · Period ending:

DSGN logo

DSGN SG&A Expense Growth

Latest reported8.67%
DSGN Quarterly SG&A Growth (QoQ) (0.00% → 8.67%)
High-resolution chart · PNG

DSGN sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Design Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
8.6728%
12.2892%
0.4659%
-19.019%
15.6715%
11.1087%
3.8215%
-3.4681%
-1.5656%
11.925%
-26.1635%
0.5965%
-6.5698%
15.2618%
5.0941%
12.523%
-5.7905%
21.6623%
35.4539%
5.188%
47.3684%
52.1922%
142.5358%
12.933%
11.5979%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.